Rural men had almost twice the risk of prostate cancer biochemical recurrence as urban men in the US. Patients living in rural areas may be at an increased risk for prostate cancer biochemical ...
A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph's Health Care London (Lawson), and University Health Network (UHN) has ...
For more than 80 years, men have been told that testosterone fuels prostate cancer. But a more nuanced picture has emerged ...
AZoLifeSciences on MSN
Genomic test can accurately identify early recurrence risk in prostate cancer patients
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...
Reply to: Oxaliplatin Dosing and Toxicity: A Cautionary Perspective on Efficacy Biochemical recurrence (BCR) of prostate cancer (PCa) after definitive surgery and/or radiation (including salvage ...
Cardiovascular (CV) disease is a leading cause of death among patients with prostate cancer. | Cardiovascular (CV) disease is ...
ASCO GU 2025 had groundbreaking advancements in genitourinary cancer treatments, focusing on prostate cancer, renal cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback